// App-Quantinova.ai

1522 : The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease

Researchers

Presenter

  • Sarah Luebker

Principal Investigators

  • Shervin Assassi

  • Jessica Gordon

  • Elana Bernstein

  • Virginia Steen

  • Ami Shah

  • Laura Hummers

  • Carrie Richardson

  • Dinesh Khanna

  • Flavia Castelino

  • Lorinda Chung

  • Faye Hant

  • Vicki Shanmugam

  • John VanBuren

  • Jessica Alvey

  • Monica Harding

  • Luke Evnin

  • Nora Sandorfi

Medical Centers

  • Vanderbilt University Medical Center, Nashville, TN

  • McGovern Medical School, University of Texas, Houston, TX

  • Hospital for Special Surgery, New York, NY.

  • Columbia University, New York, NY

  • George Washington University School of Medicine, Washington, DC

  • Johns Hopkins Oncology, Baltimore, MD

  • Johns Hopkins University, Baltimore, MD

  • Northwestern University, Chicago, IL

  • Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, United States.

  • Massachusetts General Hospital, Boston, MA

  • Medcl Univ of South Carolina, Charleston, SC

  • Georgetown University, Washington, DC

  • University of Utah, Salt Lake City, UT

  • Scleroderma Research Foundation, Brisbane, CA

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved